Clik here to view.
pSivida CEO to Present at ISOPT Clinical Meeting in Berlin in July 2015
WATERTOWN, Mass. pSivida Corp. (NASDAQ:PSDV; ASX:PVA), a leader in the development of sustained release drug delivery products for treating eye diseases, today announced Dr. Paul Ashton, president...
View ArticleClik here to view.
Japanese Biotech JCR Pharmaceuticals Selects Medidata’s Cloud-Based Platform...
NEW YORK Medidata (NASDAQ: MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that its cloud-based technology platform has been...
View ArticleClik here to view.
マシモがパルスオキシメーターMightySat RxでCEマークを取得
スイス・ヌーシャテル （ビジネスワイヤ） — マシモ（NASDAQ: MASI）は本日、フィンガーチップパルスオキシメーターMightySat™ RxをCEマーク適用国で臨床使用するためのCEマーク取得とフルマーケットリリースを発表しました。MightySat™ Rxは世界の一流病院で利用されているのと同じ“Masimo SET® Measure-Through Motion and Low...
View ArticleClik here to view.
エリテックが2件の肯定的なDSMB評価結果を発表
仏リヨン （ビジネスワイヤ） — 急性白血病および医療ニーズが満たされていないその他の腫瘍適応症を対象に革新的な「腫瘍飢餓化」治療薬の開発に当たっているフランスのバイオ製薬企業エリテック・ファーマ（Paris:ERYP）（ADR:EYRYY）（Euronext Paris – ERYP; OTC US –...
View ArticleClik here to view.
Cardiac Dimensions Announces Initial Enrollments in REDUCE FMR Clinical Trial
KIRKLAND, Wash. Cardiac Dimensions® today announced that the first patients have been enrolled in the REDUCE FMR clinical trial. REDUCE FMR is a prospective, double-blind, randomized multi-center...
View ArticleClik here to view.
Biogen and Sobi Announce European Medicines Agency Validates ALPROLIX®...
CAMBRIDGE, Mass. & STOCKHOLM Biogen (NASDAQ: BIIB) and Swedish Orphan Biovitrum AB (publ) (Sobi) (STO: SOBI) today announced that the European Medicines Agency (EMA) has accepted the Marketing...
View ArticleClik here to view.
REVOLVE™ Fat Grafting System by Acelity Now Available in Europe
SAN ANTONIO Acelity, a global wound care and regenerative medicine company, announced today that its patented REVOLVE™ System is now available in Europe. REVOLVE™ System offers fast, efficient and...
View ArticleClik here to view.
台湾の大手OSATが先進的半導体製造向けのゼータ・インスツルメンツ製計測システムを採用
米国カリフォルニア州サンノゼ （ビジネスワイヤ） — ゼータインスツルメンツ社は本日、台湾のOSAT（後工程受託製造）メーカーから、3台目の全自動即長システムZeta-580を受注したとアナウンスしました。OSATは2.5次元実装やFOWLP（ファンアウト型ウエハレベルパッケージ）などの先端半導体パッケージングにおける生産管理向けに採用することを決定したとのことです。...
View ArticleClik here to view.
业内领先的台湾OSAT采用泽塔仪器的测量系统进行先进半导体制造
加利福尼亚州圣何塞 (美国商业资讯)–泽塔仪器公司今天宣布，一家全球领先的台湾半导体外包封装测试企业（OSAT）决定采购第三台Zeta-580全自动测量系统，用来对其半导体先进封装的研发和生产进行监控，主要包括2.5D 互连技术(2.5D Interconnect)和Fan-Out晶圆级封装（FOWLP）。 基于Z点阵TM...
View ArticleClik here to view.
Leading Taiwan OSAT Adopts Zeta Instruments Metrology System for Advanced...
SAN JOSE, Calif. Zeta Instruments, Inc., announced today that a leading Taiwan based outsourced semiconductor assembly and test (OSAT) ordered its third Zeta-580™ automated metrology system for...
View ArticleClik here to view.
Gynesonics’ Sonata™ System Winner of 2015 Medical Design Excellence Award
REDWOOD CITY, Calif. Gynesonics, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, today announced that its Sonata System was...
View ArticleClik here to view.
Stemgent, a ReproCELL Group Company Launches a New High Performance...
YOKOHAMA, Japan We are pleased to announce that Stemgent Inc. (Cambridge, MA), a ReproCELL Group Company (Yokohama, Japan – JASDAQ: 4978) has launched its new Stemgent StemRNA™-SR Reprogramming Kit,...
View ArticleClik here to view.
SpineGuard Obtains Regulatory Clearance to Sell PediGuard® in the World’s...
PARIS & SAN FRANCISCO SpineGuard (FR0011464452 – ALSGD) announced today that it has received regulatory clearance to market its Classic PediGuard® products in China. “This regulatory clearance...
View ArticleClik here to view.
土耳其顶尖大学医院采用Masimo SpHb用于血红蛋白的连续无创监测
瑞士纳沙泰尔 (美国商业资讯) — Masimo (NASDAQ: MASI)今天宣布，土耳其Malatya 的Turgut Ozal医疗中心肝病医院已安装了Masimo的无创连续血红蛋白(SpHb®)技术，用于监测手术患者。...
View ArticleClik here to view.
トルコの一流大学病院が非侵襲的・連続的ヘモグロビン測定でマシモのSpHb技術を導入
スイス・ヌーシャテル （ビジネスワイヤ） — マシモ（NASDAQ: MASI）は本日、トルコ・マラティヤのトゥルグト・オザル医療センター肝臓病院が外科患者をモニタリングするためにマシモの非侵襲的・連続的ヘモグロビン（SpHb®）測定技術を導入したと発表しました。...
View ArticleClik here to view.
Clik here to view.
蔓越莓汁可能有助于预防心脏病和糖尿病的危险因素
马萨诸塞州LAKEVILLE-MIDDLEBORO (美国商业资讯)–一项最新研究1显示，饮用低热量蔓越莓汁鸡尾酒可能有助于降低一些慢性病的风险，这些慢性病是世界各地位居前列的死因，包括心脏病、糖尿病和卒中。鉴于世界卫生组织估计这三种疾病的全球年致死人数达1560万例，该发现是一条受人欢迎的新闻。2...
View ArticleClik here to view.
Overcoming Challenges in Sequence Analysis of FFPE Tissue Due to...
BOLOGNA, Italy Silicon Biosystems, a Bologna (Italy) and San Diego (CA, USA) based biotech company that is part of the pharmaceutical Menarini Group, presented recent findings obtained with its...
View ArticleClik here to view.
MST Raises Investment for Market Expansion
YOKNEAM, Israel MST – Medical Surgery Technologies Ltd., a leader in the field of image-guided surgical systems, has announced the closing of its Series C investment round. The $12.5 million...
View ArticleClik here to view.
Israeli Implant Company A.B. Dental Devices Ltd. to Enter a Partnership with...
ASHDOD, Israel Implant company A.B. Dental from Israel signed a triple partnership agreement to distribute dental implants and provide training courses in China, Hong Kong, and Macau. The agreement...
View Article